| Various signaling pathways in multiple myeloma cells and effects of treatment on these pathways A Dehghanifard, S Kaviani, S Abroun, M Mehdizadeh, S Saiedi, A Maali, ... Clinical Lymphoma Myeloma and Leukemia 18 (5), 311-320, 2018 | 47 | 2018 |
| CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy S Ghaffari, N Khalili, N Rezaei Journal of Experimental & Clinical Cancer Research 40 (1), 269, 2021 | 46 | 2021 |
| A review on leukemia and iPSC technology: application in novel treatment and future A Maali, A Atashi, S Ghaffari, R Kouchaki, F Abdolmaleki, M Azad Current Stem Cell Research & Therapy 13 (8), 665-675, 2018 | 35 | 2018 |
| Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy S Ghaffari, M Torabi-Rahvar, S Aghayan, Z Jabbarpour, K Moradzadeh, ... BMC immunology 22 (1), 43, 2021 | 33 | 2021 |
| IL‐35, a double‐edged sword in cancer Z Yazdani, A Rafiei, M Golpour, P Zafari, M Moonesi, S Ghaffari Journal of Cellular Biochemistry 121 (3), 2064-2076, 2020 | 33 | 2020 |
| Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia M Mosleh, M Mehrpouri, S Ghaffari, Z Saei, M Agaeipoor, F Jadali, ... Scandinavian journal of clinical and laboratory investigation 80 (2), 87-92, 2020 | 13 | 2020 |
| Impact of Various Culture Conditions on Ex Vivo Expansion of Polyclonal T‐cells for Adoptive Immunotherapy S Ghaffari, M Torabi‐Rahvar, A Omidkhoda, N Ahmadbeigi APMIS 127 (12), 737-745, 2019 | 12 | 2019 |
| Eosinophils in the tumor microenvironment: implications for cancer immunotherapy S Ghaffari, N Rezaei Journal of Translational Medicine 21 (1), 551, 2023 | 8 | 2023 |
| Induced pluripotent stem cell meets severe combined immunodeficiency R Kouchaki, B Abd-Nikfarjam, A Maali, S Abroun, F Foroughi, S Ghaffari, ... Cell Journal (Yakhteh) 22 (Suppl 1), 1, 2020 | 4 | 2020 |
| Advances in natural killer cell therapies for breast cancer SZF Kiaei, A Nouralishahi, M Ghasemirad, M Barkhordar, S Ghaffari, ... Immunology and Cell Biology 101 (8), 705-726, 2023 | 3 | 2023 |
| The Correlation Between Plasma Levels of Vitamin D and Epigenetic Alterations of Treg-Specific Demethylated Region (TSDR) in Rheumatoid Arthritis Patients M Taghadosi, S Bilvayeh, S Ghaffari, N Iranshahi, A Esfandiari, P Zafari Acta Medica Iranica 57 (6), 342-347, 2019 | 3 | 2019 |
| Methylation Status of SMG1 Gene Promoter in Multiple Myeloma H Gholipour, S Abroun, M Noruzinia, S Ghaffari, A Maali, M Azad Iranian Journal of Blood & Cancer 10 (4), 2-4, 2018 | 2 | 2018 |
| Applications of single‐cell omics for chimeric antigen receptor T cell therapy S Ghaffari, M Saleh, B Akbari, F Ramezani, HR Mirzaei Immunology, 2024 | 1 | 2024 |
| Evaluation of Wilms’ Tumor (WT1) Gene Methylation in Acute Lymphocytic Leukemia Patients F Alimohammadi, S Alizadeh, S Ghaffari, F Nadali, M Azad Basic & Clinical Cancer Research 10 (4), 32-35, 2018 | 1 | 2018 |
| The effect of serum origin on cytokines induced killer cell expansion and function Z Jabbarpour, SS Aghayan, K Moradzadeh, S Ghaffari, N Ahmadbeigi BMC immunology 24 (1), 28, 2023 | | 2023 |
Naser AhmadbeigiTehran University of Medical Sciences,Digestive Disease Research Center,Cell-Based Therapy ResearchVerified email at sina.tums.ac.ir
